Companies: 10,795·Total market cap: $144.5T
Comera Life Sciences Holdings, Inc.

Comera Life Sciences Holdings, Inc.

CMRAOTCHealthcare● Active
$0.00
+$0.00(+9900.00%)
Market Cap$3074
P/E Ratio
52W High$0.0002
52W Low$0.0001

Comera Life Sciences Holdings, Inc. (CMRA) · Income Statement

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · CMRA · as of 2026-06-09

Financial statements

Revenue · Gross Profit · Net Income
Breakdown2022-122021-122020-12
Revenue
Revenue$0.63M$0.32M$0.44M
Cost of Revenue$0.21M$0.16M$0.10M
Gross Profit$0.42M$0.16M$0.34M
Gross Margin %(computed)66.77%49.66%76.43%
Operating Expenses
R&D Expenses$1.74M$1.75M$1.26M
G&A Expenses$10.65M$3.94M$1.20M
Total Operating Expenses$12.39M$5.69M$2.47M
Operating Income($11.97M)($5.54M)($2.13M)
Operating Margin %(computed)-480.34%
Interest Income$0.00M$0.00M$0.01M
Interest Expense$0.02M$0.00M$0.00M
Income Before Tax($18.00M)($5.45M)($2.13M)
Income Tax Expense$0.00M$0.00M$0.00M
Net Income($18.00M)($5.45M)($2.13M)
Net Margin %(computed)-479.88%
Per Share & EBITDA
EPS (Basic)$-1.76$-0.29$-0.11
Wtd Avg Shares10.45M19.09M19.09M
EBITDA($17.89M)($5.37M)($2.04M)
EBITDA Margin %(computed)-460.08%

Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M

Explore more Comera Life Sciences Holdings, Inc. data

About Comera Life Sciences Holdings, Inc. (CMRA) Income Statement

Comera Life Sciences Holdings, Inc. (CMRA) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2022, CMRA reported revenue of $0.00B, gross profit of $0.00B (gross margin 66.77%), and net income of ($0.02B) — a net profit margin of -2843.79%.

Frequently asked questions

CMRA · 4 questions

Comera Life Sciences Holdings, Inc. (CMRA) reported revenue of $0.00B for 2022, up 97.9% year-over-year.

CMRA revenueCMRA salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09